Peer support may boost HIV prevention and addiction treatment for young drug users in india

NCT ID NCT06510192

Not yet recruiting Disease control Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests whether a peer-led program called Yuva Sath can help young people (ages 18-29) who inject drugs stay engaged in substance use treatment and HIV prevention. The program includes six one-on-one sessions with a peer counselor and weekly text check-ins. Researchers will enroll 60 participants to see if the approach is feasible and acceptable, and whether it improves treatment attendance and reduces risky behaviors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Yuva Sath peer-led behavioral intervention (6 one-on-one sessions + weekly text check-ins)
What this could lead to: If it works, this could point toward a scalable, low-cost way to help young people who inject drugs stay in treatment and reduce HIV risk.
What could go wrong: This is a very small pilot study (60 people) testing feasibility, not effectiveness. It may not show clear benefits or be generalizable to other settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS opiate dependence substance-related disorder HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV SUBSTANCE USE DISORDERS

More trials for these conditions

Other studies related to the condition(s) this trial covers.